1438
C. Della Rosa et al. / Tetrahedron Letters 48 (2007) 1435–1438
5. Della Rosa, C.; Paredes, E.; Kneeteman, M.; Mancini,
P. M. E. Lett. Org. Chem. 2004, 1, 369–371.
(300 MHz, CDCl3) d: 1.71 (s, 3H); 2.24 (s, 3H); 2.35 (s,
3H); 2.05–2.7 (m, 4H); 3.69 (s, 3H); 3.79 (m, 1H); 5.40 (br s,
1H); 6.20 (d, 1H, J = 2.1 Hz); 6.35 (dd, 1H, J = 8.1–
2.1 Hz); 7.1 (d, 1H, J = 8.1 Hz); 7.32 (d, 2H, J = 8 Hz); 7.82
(d, 2H, J = 8 Hz). 13C NMR (75 MHz) d: 23.6; 24.7; 27.1;
37.2; 52.5; 53.6; 56.6; 114.2; 117.8; 124.3; 127.0; 128.7;
129.2; 130.2; 135.9; 137.3; 141.7; 144.1; 172.0. Compound
8c: 1H NMR (300 MHz, CDCl3) d: 1.71 (s, 3H); 2.22 (s,
3H); 2.35 (s, 3H); 2.1–2.7 (m, 4H); 3.68 (s, 3H); 3.82 (m,
1H); 5.41 (br s, 1H); 6.24 (d, 1H, J = 8.1 Hz); 6.60 (dd, 1H,
J = 8.1–1.5 Hz); 6.90 (d, 1H, J = 1.5 Hz); 7.32 (d, 2H,
J = 8 Hz); 7.82 (d, 2H, J = 8 Hz). 13C NMR (75 MHz) d:
23.2; 24.5; 25.4; 30.2; 34.5; 51.5; 53.4; 60.0; 113.6; 123.7;
127.4; 128.4; 129.8; 131.4; 131.6; 135.7; 137.3; 140.5; 142.6;
6. General procedure. The temperature, the length of the
reaction and the diene/dienophile ratio are given in Tables 1
and 2. An ampoule containing 1.0 mmol of the dienophile
and the required amount of diene in 0.5 ml of dry benzene
was cooled in liquid nitrogen, sealed and then heated in an
oil bath. After the reaction time was completed, it was
cooled once more in liquid nitrogen and opened. The
solution was evaporated and the residue purified by column
chromatography in silica gel or alumina using hexane/ethyl
acetate mixtures as the eluent. Biolatto, B.; Kneeteman, M.;
Paredes, E.; Mancini, P. J. Org. Chem. 2001, 66, 3906–3912.
7. (a) Biolatto, B.; Kneeteman, M.; Paredes, E.; Mancini, P.
J. Org. Chem. 2001, 66, 3906–3912; (b) Biolatto, B.;
Kneeteman, M.; Mancini, P. Tetrahedron Lett. 1999, 40,
3343–3346.
1
172.0. Compound 8d: H NMR (300 MHz, CDCl3) d: 1.69
(s, 3H); 2.22 (s, 3H); 2.35 (s, 3H); 2.1–2.7 (m, 4H); 3.68 (s,
3H); 3.81 (m, 1H); 5.35 (br s, 1H); 6.20 (d, 1H, J = 8.1 Hz);
6.35 (dd, 1H, J = 8.1–2.1 Hz); 7.1 (d, 1H, J = 2.1 Hz); 7.32
(d, 2H, J = 8 Hz); 7.82 (d, 2H, J = 8 Hz). 13C NMR
(75 MHz) d: 23.7; 24.7; 30.2; 34.7; 51.2; 53.6; 59.3; 113.6;
118.1; 124.0; 127.6; 128.5; 130.1; 131.0; 134.2; 137.1; 137.8;
142.1; 144.6; 172.0. Compound 9b: 1H NMR (300 MHz,
CDCl3) d: 2.35 (s, 3H); 3.89 (s, 3H); 7.31–7.34 (m, 3H); 7.65
(m, 2H); 7.82 (d, 2H, J = 8 Hz); 8.1 (s, 1H); 8.3 (dd, 1H,
J = 8.1–2.1 Hz). 13C NMR (75 MHz) d: 24.6; 51.7; 109.3;
111.4; 119.6; 121.1; 123.6; 126.5; 128.4; 129.3; 131.0; 135.2;
137.8; 144.2; 167. HRMS m/z 329.3796 (calcd C17H15O4NS,
329.3789). Compound 10a: 1H NMR (300 MHz, CDCl3) d:
2.37 (s, 3H); 5.0 (br s, 1H); 6.45 (d, 1H, J = 3.1 Hz); 6.85
(dd, 1H, J = 8.1–1.2 Hz); 7.21 (d, 1H, J = 1.2 Hz), 7.27 (d,
1H, J = 8.1 Hz); 7.32 (d, 2H, J = 8 Hz); 7.82 (d, 2H,
J = 8 Hz). 13C NMR (75 MHz) d: 24.5; 102.5; 104.4; 110.9;
112.5; 118.6; 127.6; 128.7; 129.7; 130.3; 135.2; 143.6; 152.7.
HRMS m/z 311.3642 (calcd C15H13O3SN, 311.3636).
Compound 10b: 1H NMR (300 MHz, CDCl3) d: 2.35 (s,
3H); 3.90 (s, 3H); 5.20 (br s, 1H); 6.74 (dd, 1H, J = 8.4–
2.2 Hz); 7.05 (d, 1H, J = 8.4 Hz); 7.32 (d, 2H, J = 8 Hz);
7.75 (d, 1H, J = 2.2 Hz); 7.82 (d, 2H, J= 8 Hz); 8.20 (s, 1H).
13C NMR (75 MHz) d: 24.5; 52.0; 104.2; 109.1; 112.6; 113.8;
128.5; 128.8; 129.1; 129.7; 131.4; 135.0; 144.4; 153.1; 167.1.
HRMS m/z 345.3790 (calcd C17H15O5NS, 345.3783).
Compound 11a: 1H NMR (300 MHz, CDCl3) d: 2.45 (s,
6H); 3.89 (s, 3H); 7.05 (d, 1H, J = 8.6 Hz); 7.32 (d, 2H,
J = 8 Hz); 7.40 (m, 2H); 7.61 (d, 1H, J = 2.1 Hz); 7.82 (d,
2H, J = 8 Hz). 13C NMR (75 MHz) d: 24.5; 24.8; 52.1;
109.6; 112.3; 119.5; 121.7; 129.5; 130.5; 131.7; 132.4; 135.8;
8. Danishefsky, S.; Kitahara, T.; Yan, C. F.; Morris, J.
J. Am.Chem. Soc. 1979, 101, 6996–7000.
9. Spectral data. Compounds 5a, 5b, 6a and 6b, both of the
homologous benzenesulfonylated derivatives were reported
by Wenkert et al.2 Compound 6c: 1H NMR (300 MHz,
CDCl3) d: 2.35 (s, 3H); 2.40 (s, 3H); 3.89 (s, 3H); 7.20 (d,
1H, J = 8.1 Hz); 7.32 (d, 2H, J = 8 Hz); 7.41 (d, 1H,
J = 8.1 Hz); 7.71 (s, 1H); 7.82 (d, 2H, J = 8 Hz); 7.95 (s,
1H). 13C NMR (75 MHz) d: 24.4; 24.7; 51.6; 108.9; 118.8;
120.7; 126.7; 128.3; 129.2; 131.2; 133.2; 135.2; 144.1; 165.0.
HRMS m/z 343.4063 (calcd C18H17O4NS, 343.4059).
Compound 6d: 1H NMR (300 MHz, CDCl3) d: 2.35 (s,
3H); 2.40 (s, 3H); 3.89 (s, 3H); 7.1–7.30 (m, 2H); 7.32 (d,
2H, J = 8 Hz); 7.82 (d, 2H, J = 8 Hz); 7.95 (s, 1H); 8.15 (d,
1H, J = 8.1 Hz). 13C NMR (75 MHz) d: 24.3; 51.5; 108.9;
111.5; 119.3; 121.6; 123.8; 128.4; 126.9; 127.6; 128.8; 130.5;
135.3; 136.0; 143.8; 165.0. Compound 7a: 1H NMR
(300 MHz, CDCl3) d: 1.85 (s, 6H); 2.1–2.5 (m, 4H); 2.32
(s, 3H); 3.1–3.5 (m, 6H); 3.68 (s, 3H); 5.2 (br s, 1 H); 5.41
(m, 1H); 7.32 (d, 2H, J = 8 Hz); 7.82 (d, 2H, J = 8 Hz). 13
C
NMR (75 MHz) d: 23.5; 24.6; 28.1; 32.6; 33.7; 37.1; 46.6;
52.9; 59.2; 116.7; 121.6; 123.7; 127.6; 129.7; 132.5; 135.1;
134.6; 137.7; 170.0. HRMS m/z 412.5335 (calcd
C23H26O4NS, 412.5331). Compound 7b: 1H NMR
(300 MHz, CDCl3) d: 1.70 (s, 3H); 1.72 (s, 3H); 2.05–2.45
(m, 4H); 2.35 (s, 3H); 2.7 (m, 4H); 3.5 (m, 1H); 3.68 (s, 3H);
5.1 (br s, 1H); 5.4 (m, 1H); 7.32 (d, 2H, J = 8 Hz); 7.82 (d,
2H, J = 8 Hz). 13C NMR (75 MHz) d: 23.3; 23.6; 24.6; 27.5;
28.6; 37.2; 40.3; 47.8; 53.2; 58.6; 116.4; 121.6; 123.7; 128.4;
130.2; 131.6; 135.1; 135.8; 137.6; 143.5; 171.0. Compound
7c: 1H NMR (300 MHz, CDCl3) d: 1.70 (s, 3H); 1.72 (s,
3H); 2.05–2.45 (m, 4H); 2.35 (s, 3H); 2.8 (m, 4H); 3.4 (m,
1H); 3.68 (s, 3H); 5.0 (br s, 1H); 5.5 (m, 1H); 7.32 (d, 2H,
J = 8 Hz); 7.82 (d, 2H, J = 8 Hz). 13C NMR (75 MHz) d:
23.1; 23.6; 24.7; 32.1; 32.6; 34.1; 35.6; 44.4; 53.5; 61.4; 116.7;
121.6; 124.5; 128.2; 130.3; 132.2; 134.7; 135.0; 137.6; 142.7;
1
140.5; 144.6; 160.1. Compound 11b: H NMR (300 MHz,
CDCl3) d: 2.35 (s, 3H); 2.40 (s, 3H); 3.89 (s, 3H); 7.04 (s,
1H); 7.2–7.40 (m, 2H); 7.32 (d, 2H, J = 8 Hz); 7.7 (d, 1H,
J = 8.4 Hz); 7.82 (d, 2H, J = 8 Hz). 13C NMR (75 MHz) d:
24.5; 52.1; 109.7; 112.4; 119.5; 121.7; 129.6; 130.5; 131.7;
132.4; 135.9; 140.5; 145.2, 160.1. Compound 12b: 1H NMR
(300 MHz, CDCl3) d: 2.35 (s, 3H); 3.90 (s, 3H); 7.1–7.25 (m,
2H); 7.32 (d, 2H, J = 8 Hz); 7.5–7.7 (m, 3H); 7.82 (d, 2H,
J = 8 Hz). 13C NMR (75 MHz) d: 24.5; 52.1; 109.7; 112.1;
119.8; 121.3; 123.6; 128.5; 130.6; 130.8; 135.7; 142.4; 144.5;
160.1. Compound 13a: 1H NMR (300 MHz, CDCl3) d: 2.35
(s, 3H); 5.0 (br s 1H); 6.21 (d, 1H, J = 3.0 Hz); 6.63 (dd, 1H,
J = 8.1–1.1 Hz); 7.0 (d, 1H, J = 1.1 Hz); 7.25 (d, 1H,
J = 3.0 Hz); 7.32 (d, 2H, J = 8 Hz); 7.38 (d, 1H,
J = 8.1 Hz); 7.82 (d, 2H, J = 8 Hz). 13C NMR (75 MHz)
d: 24.5; 97.3; 102.6; 113.6; 118.4; 120.5; 120.8; 128.4; 130.7;
135.8; 137.7; 143.8; 150.6. Compound 13b: 1H NMR
(300 MHz, CDCl3) d: 2.35 (s, 3H); 3.90 (s, 3H); 5.12 (br
s, 1H); 6.95 (s, 1H); 7.1–7.28 (m, 2H); 7.32 (d, 2H,
J = 8 Hz); 7.80 (d, 1H, J = 8.4 Hz); 7.82 (d, 2H, J = 8 Hz).
13C NMR (75 MHz) d: 24.5; 52.6; 97.9; 110.4; 115.7; 121.6;
123.9; 130.5; 131.8; 133.7; 135.9; 143.8; 151.2.
1
171.0. Compound 7d: H NMR (300 MHz, CDCl3) d: 1.72
(s, 6H); 2.06–2.41 (m, 4H); 2.35 (s, 3H); 2.7 (m, 4H); 3.4 (m,
1H); 3.68 (s, 3H); 5.1 (br s, 1H); 5.4 (m, 1H); 7.32 (d, 2H,
J = 8 Hz); 7.82 (d, 2H, J = 8 Hz). 13C NMR (75 MHz)d:
23.1; 23.3; 24.6; 27.3; 32.5; 36.6; 40.5; 44.7; 52.4; 61.4; 116.9;
121.3; 124.5; 128.0; 130.2; 132.4; 134.8; 135.2; 137.8; 142.6;
1
171.0. Compound 8a: H NMR (300 MHz, CDCl3) d: 1.69
(s, 3H); 2.21 (s, 3H); 2.35 (s, 3H); 2.1–2.6 (m, 4H); 3.68 (s,
3H); 3.81 (m, 1H); 5.35 (br s, 1H); 6.25 (d, 1H, J = 8.1 Hz);
6.60 (dd, 1H, J = 8.1–1.5 Hz); 6.90 (d, 1H, J = 1.5 Hz); 7.32
(d, 2H, J = 8 Hz); 7.82 (d, 2H, J = 8 Hz). 13C NMR
(75 MHz) d: 23.7; 24.7; 25.4; 27.1; 37.2; 53.7; 54.8; 56.5;
114.6; 124.2; 127.5; 128.4; 130.4; 130.9; 131.1; 135; 137.7;
141.6; 142.3; 172.1. HRMS m/z 410.5227 (calcd
C23H24O4SN, 410.5223). Compound 8b: 1H NMR